Lataa...
The Low-Dose (7.5 mg/day) Pioglitazone Therapy
Pioglitazone is one of thiazolidinedione derivatives, which stimulates nuclear peroxisome proliferator-activated receptor gamma and improves glucose and lipid metabolism and insulin sensitivity. A recent systematic review and meta-analysis showed that pioglitazone therapy was associated with a lower...
Tallennettuna:
| Julkaisussa: | J Clin Med Res |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elmer Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5593428/ https://ncbi.nlm.nih.gov/pubmed/28912917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3144w |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|